GSK
GSK
GSK
$50.02
-1.20% Oct 21 close
Sector n/a
Compare
GSKSPY
1W
+4.5%
1M
-2.1%
3M
-0.6%
6M
-8.6%
YTD
+4.7%
1Y
+17.9%
Live chart
Loading live chart…
For information only · Important disclosures
Grades vs sector
No sector grades for GSK yet. Grades rank S&P 1500 stocks within their sector and refresh after each daily data run, so a stock outside that index or newly covered has none.
Our models
Not held by any of our 5 live models right now.
Quality Growth
Outside this model's universe or screens
Momentum Top 15Outside this model's universe or screens
Momentum BlendNot in the current book
New Highs GrowthOutside this model's universe or screens
Coteau Long BookNot in the current book
News
More newsNo recent headlines.
Key stats
52-week range$41.76 – $59.60
Valuation and fundamentals
Valuation & fundamentals
No US-GAAP 10-K/10-Q financials in SEC data (foreign filers report on Form 20-F, often under IFRS).
Earnings
Next report: 2026-10-28 · before open · EPS est 1.33
EstimateActual (beat)Actual (miss)
| Report | EPS est | Actual | Surprise |
|---|---|---|---|
| 2026-07-28 | 1.25 | 1.34 | +7.2% |
| 2026-04-29 | 1.16 | 1.26 | +7.9% |
| 2026-02-04 | 0.62 | 0.70 | +11.9% |
| 2025-10-29 | 1.26 | 1.46 | +15.4% |
| 2025-07-30 | 1.11 | 1.24 | +11.7% |
| 2025-04-30 | 1.04 | 1.20 | +15.6% |
| 2025-02-05 | 0.49 | 0.58 | +18.8% |
| 2024-10-30 | 1.16 | 1.29 | +11.0% |
Stats refreshed 2026-10-21 18:19:18 ET from Yahoo Finance (yfinance). "–" means the data isn't available. Refresh now
coteau
Independent research · Not investment advice · Important disclosures · Contact desk@coteau.app
Coteau Systematic Strategies publishes stock research and model portfolios. Results are hypothetical unless marked Live. Data: Yahoo Finance (15-min delayed), SEC EDGAR and the House Clerk.
Beta 0.9 · Oct 21, 2026